(ALKS) |
0 (0%) 10-10 16:19 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 37.40 |
Resistance 1: | 32.02 |
Pivot price: | 29.75 |
Support 1: | 27.79 |
Support 2: | 25.17 |
52w High: | |
52w Low: |
EPS | 2.070 |
Book Value | 9.840 |
PEG Ratio | 0.00 |
Gross Profit | 7.754 |
Profit Margin (%) | 23.15 |
Operating Margin (%) | 23.80 |
Return on Assets (ttm) | 10.5 |
Return on Equity (ttm) | 23.9 |
Fri, 10 Oct 2025
What earnings revisions data tells us about ALKS - July 2025 EndofMonth & Reliable Volume Spike Trade Alerts - newser.com
Thu, 09 Oct 2025
What Do Recent Gains Mean for Alkermes Stock Value in 2025? - simplywall.st
Wed, 08 Oct 2025
Alkermes upgraded at RBC Capital Markets ahead of key catalyst - MSN
Wed, 08 Oct 2025
RBC Capital Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $45 - 富途牛牛
Tue, 07 Oct 2025
Robeco Institutional Asset Management B.V. Buys 36,467 Shares of Alkermes plc $ALKS - MarketBeat
Sun, 28 Sep 2025
How Investors May Respond To Alkermes (ALKS) Phase 2 Alixorexton Narcolepsy Trial Outperformance - Sahm
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |